Current Situation and Prospect of Pharmacoeconomic Evaluation of Hemophilia in China
In 2018, hemophilia, one of the first ones, entered into the catalogue of Rare Disease in China. However, drug accessibility and affordability have been the challenges for hemophilia patients. Therefore, a comprehensive evaluation of the cost and efficacy of hemophilia drugs is essential to push for...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Chinês |
| Publicat: |
Editorial Office of Journal of Rare Diseases
2022-10-01
|
| Col·lecció: | 罕见病研究 |
| Matèries: | |
| Accés en línia: | https://jrd.chard.org.cn/article/doi/10.12376/j.issn.2097-0501.2022.04.018 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|